Atlas Trials

Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

Clinical trial NCT02145078 · TERMINATED

Trial details

NCT number
NCT02145078
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Start date
2014-06-01
Primary completion
2015-06-18
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.